CAMP4 Therapeutics Corporation (CAMP) Earnings History
Net Loss37 years of earnings data (1989–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
CAMP4 Therapeutics Corporation (CAMP) Earnings Overview
As of June 28, 2026, CAMP4 Therapeutics Corporation (CAMP) reported trailing twelve-month net income of -$86M, reflecting +0.4% year-over-year growth. The company earned $-1.49 per diluted share over the past four quarters, with a net profit margin of -2298.5%.
Looking at the long-term picture, CAMP's historical earnings data spans multiple years. The company achieved its highest annual net income of $45M in fiscal 2012.
CAMP4 Therapeutics Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RARE (-$609M net income, -85.4% margin), FOLD (-$27M net income, -4.3% margin), ACAD ($376M net income, 36.5% margin), CAMP has room to improve margins relative to the peer group. Compare CAMP vs RARE →
CAMP Earnings vs Peers
Earnings metrics vs comparable public companies
CAMP Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$80M | -55.2% | -$52M | $-2.65 | -2298.5% | -1488.3% |
| 2024 | -$52M | -5.1% | -$53M | $-2.66 | -7943.4% | -8142.3% |
| 2023 | -$49M | -11.5% | -$52M | $-4.07 | -14083.1% | -14822.6% |
| 2022 | -$44M | -41.9% | -$45M | $-0.90 | - | - |
| 2021 | -$31M | -47.2% | -$15M | $-0.88 | -10.5% | -5.2% |
| 2020 | -$21M | +73.1% | -$4M | $-0.62 | -6.9% | -1.3% |
| 2019 | -$79M | -528.2% | -$17M | $-2.34 | -21.5% | -4.6% |
| 2018 | $18M | +10.7% | $20M | $0.52 | 5.1% | 5.4% |
| 2017 | $17M | +332.4% | $8M | $0.46 | 4.5% | 2.2% |
| 2016 | -$7M | -142.2% | $1M | $-0.20 | -2.0% | 0.4% |
| 2015 | $17M | +2.6% | $28M | $0.46 | 6.0% | 10.0% |
| 2014 | $17M | +39.9% | $25M | $0.45 | 6.6% | 10.0% |
| 2013 | $12M | -73.6% | $18M | $0.33 | 5.0% | 7.8% |
| 2012 | $45M | +755.2% | $16M | $1.49 | 24.7% | 8.8% |
| 2011 | $5M | +258.9% | $7M | $0.18 | 3.8% | 5.3% |
| 2010 | -$3M | +69.7% | -$2M | $-0.12 | -2.9% | -1.8% |
| 2009 | -$11M | +78.2% | -$10M | $-0.43 | -9.7% | -8.9% |
| 2008 | -$50M | +41.0% | -$45M | $-2.01 | -50.5% | -45.7% |
| 2007 | -$84M | -169.8% | -$101M | $-3.52 | -59.7% | -71.5% |
| 2006 | -$31M | -314.2% | -$29M | $-1.34 | -14.0% | -13.0% |
| 2005 | $15M | +80.3% | $24M | $0.62 | 6.7% | 11.0% |
| 2004 | $8M | +41.3% | $13M | $0.36 | 3.7% | 5.9% |
| 2003 | $6M | +10.7% | $6M | $0.37 | 4.4% | 4.7% |
| 2002 | $5M | +15.6% | $8M | $0.35 | 5.2% | 8.2% |
| 2001 | $4M | -14.3% | $5M | $0.32 | 4.4% | 5.2% |
| 2000 | $5M | +473.9% | $9M | $0.37 | 4.2% | 7.1% |
| 1999 | -$1M | +0.5% | $8M | $-0.12 | -1.6% | 9.1% |
| 1998 | -$1M | +48.1% | -$3M | $-0.12 | -3.8% | -7.0% |
| 1997 | -$3M | -550.0% | -$4M | $-0.23 | -5.8% | -8.1% |
| 1996 | $600,000 | -88.0% | $700,000 | $0.05 | 1.2% | 1.4% |
| 1995 | $5M | +100.0% | $8M | $0.41 | 8.1% | 12.2% |
| 1994 | $3M | +56.3% | $4M | $0.22 | 5.5% | 8.3% |
| 1993 | $2M | -48.4% | $3M | $0.14 | 3.9% | 6.6% |
| 1992 | $3M | +93.8% | $4M | $0.30 | 8.7% | 12.0% |
| 1991 | $2M | +420.0% | $2M | $0.16 | 7.8% | 9.7% |
| 1990 | $-500,000 | -350.0% | $-300,000 | $-0.06 | -3.5% | -2.1% |
| 1989 | $200,000 | - | $300,000 | $0.03 | 1.8% | 2.8% |
Download Data
Export CAMP earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
37+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CAMP — Frequently Asked Questions
Quick answers to the most common questions about buying CAMP stock.
What is CAMP earnings per share (EPS)?
CAMP trailing twelve-month (TTM) diluted EPS is $-1.49, reflecting +0.4% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1989 to 2025 is available in the table on this page.
What is CAMP4 Therapeutics Corporation's net income?
CAMP4 Therapeutics Corporation (CAMP) trailing twelve-month net income is $-86M as of 2025. Earnings grew +0.4% year-over-year.
Is CAMP profitable?
CAMP is not currently profitable on a TTM basis, reporting a net loss of $-86M. Net margin is -2298.5%. Investors should monitor for a return to profitability.
What is CAMP's earnings growth rate?
CAMP compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1989 to 2025.
What are CAMP's profit margins?
CAMP4 Therapeutics Corporation net profit margin is -2298.5%, operating margin is -1488.3%, and gross margin is +53.1%. Below-average margins reflect competitive or cost pressures. Return on Equity is -145.1%.
Is CAMP growing earnings?
CAMP earnings growth is slowing. Current YoY EPS growth of +0.4% trails the 5-year CAGR of N/A. TTM net income is $-86M.
What was CAMP's best earnings year?
CAMP4 Therapeutics Corporation's highest annual net income on record is $45M, achieved in fiscal year 2012. Earnings history on this page spans 1989 to 2025 and includes all annual and quarterly figures.
What were CAMP's earnings last quarter?
CAMP's most recent reported quarter was Q1 2026. Net income was $-18M with diluted EPS of $-0.32. For a full breakdown of all quarters, see the quarterly earnings table on this page.